Sumitomo Pharma Co., Ltd.

SMDPY · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$1$11$2$53
Dep. & Amort.$0$5$6$6
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0-$8-$1$0
Other Non-Cash-$0-$9$4-$59
Operating Cash Flow$0-$0$11$1
Investing Activities
PP&E Inv.-$0-$1-$2-$2
Net Acquisitions$0-$2$1-$1
Inv. Purchases-$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$4$4$3
Investing Cash Flow$0-$0$2-$0
Financing Activities
Debt Repay.-$0-$1-$28$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0-$0-$0-$0
Other Fin. Act.-$0$1-$35-$16
Financing Cash Flow-$0$0-$64-$16
Forex Effect$0-$0$1$0
Net Chg. in Cash$0-$0-$62$85
Supplemental Information
Beg. Cash$0$0$85$99
End Cash$0$0$23$85
Free Cash Flow$0-$2$9-$1
Sumitomo Pharma Co., Ltd. (SMDPY) Financial Statements & Key Stats | AlphaPilot